[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100571978":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":30,"centralContacts":35,"locations":25,"responsibleParty":45,"collaborators":47,"id":53,"slug":54,"hasResults":55,"nctId":56,"briefTitle":57,"officialTitle":58,"acronym":25,"eligibilityCriteria":59,"healthyVolunteers":55,"sex":60,"minAge":61,"maxAge":62,"enrollmentInfo":63,"targetDuration":25,"studyType":66,"phases":67,"briefSummary":69,"conditions":70,"keywords":72,"overallStatus":79,"whyStopped":25,"lastUpdateSubmitDate":80,"lastUpdatePostDateStruct":81,"startDateStruct":84,"completionDateStruct":86,"leadSponsor":88,"locationsCount":25},{"fullName":5,"class":6},"Federal State Budgetary Scientific Institution \"Federal Research Centre of Nutrition, Biotechnology","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"plant-based meat analog","EXPERIMENTAL","Patients with non-alcoholic fatty liver disease will receive iso-caloric diet with modified fat and protein content: 18.8 g\u002Fday animal proteins a day will be substituted by 13.0 g\u002Fday vegetable protein; 6.0 g\u002Fday animal fat will be substituted by 19.1 g\u002Fday vegetable fat. This modification undermines substitution of a portion of meat product made of standard (animal) meat (cutlet or schnitzel) by plant-based analog, based on soy-bean source. The taste will be masked by natural food flavoring (taste of chicken).",[13],"Other: Specialized food - Plant-Based Meat Analog",{"label":15,"type":16,"description":17,"interventionNames":18},"Control - standard iso-calorie diet","PLACEBO_COMPARATOR","Iso-calorie diet (based on resting energy expenditures measurements) is provided to subjects with non-alcoholic fatty liver disease",[19],"Other: standard isocalorie diet",[21,26],{"type":6,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"Specialized food - Plant-Based Meat Analog","Experimental group receives specialized food made of plant-based (soy) meat analog. A portion of standard (animal) meat in a daily ration of the enrolled subjects is substituted by plant-based analog.",[9],null,{"type":6,"name":27,"description":28,"armGroupLabels":29,"otherNames":25},"standard isocalorie diet","Isocalorie (based on resting energy expenditures measurements) diet is provided to subjects of the control group with no modification of the protein and fat content",[15],[31],{"name":32,"affiliation":33,"role":34},"Vasily Isakov, MD, PhD, Professor","Federal Research Center of Nutrition&Biotechnology","STUDY_CHAIR",[36,41],{"name":37,"role":38,"phone":39,"phoneExt":25,"email":40},"Sergey Morozov, MD, PhD, DrSci","CONTACT","+79104681801","morosoffsv@mail.ru",{"name":42,"role":38,"phone":43,"phoneExt":25,"email":44},"Vladimir Pilipenko, MD, PhD","+74996131091","pilipenkowork@rambler.ru",{"type":46,"investigatorFullName":25,"investigatorTitle":25,"investigatorAffiliation":25,"oldNameTitle":25,"oldOrganization":25},"SPONSOR",[48,51],{"name":49,"class":50},"Group of companies EFKO","UNKNOWN",{"name":52,"class":6},"Russian Science Foundation","100571978","assessment-of-tolerability-of-specialized-food-products-made-out-of-vegetable-protein-and-their-influence-on-lipid-profile-in-patients-with-non-alcoholic-fatty-liver-disease-100571978",false,"NCT06727279","Assessment of Tolerability of Specialized Food Products Made Out of Vegetable Protein and Their Influence on Lipid Profile in Patients With Non-alcoholic Fatty Liver Disease","Assessment of Tolerability of Specialized Foods of Vegetable Proteins and Their Influence on Lipid Profile in Patients With Non-alcoholic Fatty Liver Disease","Inclusion Criteria:\n\n* Willingness to participate;\n* Confirmed diagnosis of non-alcoholic fatty liver disease based on EASL guidelines.\n\nExclusion Criteria:\n\n* Pregnancy and breastfeeding;\n* excessive alcohol intake (\\>20 g\u002Fday women and \\>30 g\u002Fday men)\n* Liver cirrhosis based on liver histology, or liver stiffness measurement (LSM \\> or =14 kPa by Fibroscan), or APRI \\> or= 1; or BARD score \\> or = 2.\n* Chronic heart failure (I-IV class by NYHA).\n* Past bariatric surgery.\n* Clinically relevant acute cardiovascular event within 6 months prior to screening.\n* Uncontrolled arterial hypertension despite optimal anti-hypertensive therapy.\n* Diabetes mellitus type 1.\n* Serum glycated hemoglobin \\[HbA1c\\] concentrations \\>9.0%.\n* Hypersensitivity to the studied product or any of its components.\n* The intake of any medications that may affect the absorption, distribution, metabolism or excretion of investigational products or may lead to the induction or inhibition of microsomal enzymes (for example, indomethacin) - from the moment of randomization to the end of treatment.\n* Any medical conditions that may significantly affect life expectancy, including known cancers;\n* Any clinically significant immunological, endocrine, haematological, gastrointestinal, neurological or psychiatric diseases;\n* Mental instability or incapacity, which may impact the ability to give informed consent, take part in the study, or affect the ability to comply with study protocol requirements.\n* Positive test for to human immunodeficiency virus antibodies .\n* Aspartate aminotransferase (AST) and\u002For ALT \\>10 x upper normal limits.\n* conjugated bilirubin \\> 26 mcmol\u002Fl (patients with Gilbert's disease are allowed to the study).\n* International normalized ratio \\>1.40.\n* Platelet count \\\u003C100 x10\\^9\u002FL due related to portal hypertension.\n* Clinically relevant renal dysfunction, including nephrotic syndrome, chronic kidney disease (determined based on the estimated glomerular filtration rate \\[eGFR\\] less than 60 ml\u002Fmin\u002F1.73 m\\^2).","ALL","18 Years","75 Years",{"count":64,"type":65},50,"ESTIMATED","INTERVENTIONAL",[68],"NA","To this single-centre randomized controlled comparative study it is planned to enroll 50 patients with non-alcoholic fatty liver disease. All these subjects will receive standard isocaloric diet for 14 days. Subjects of the main group will receive vegetable protein-and-fat cutlet or schnitzel insted of the same amount of standard (animal meat based) cutlet or schnitzel. Subjects of the control group will receive standard diet, with cutlets or schnitzels made of animal meat. It is planned to make repeated measurements of serum lipid profile and assess general well-being and tolerability of newly developed product compared to regular meal",[71],"Non-alcoholic Fatty Liver Disease NAFLD",[73,74,75,76,77,78],"non-alcoholic fatty liver disease","vegetable protein","specialized foods","plant-based meat analogs","meat substitutes","tolerability","NOT_YET_RECRUITING","2025-08-01",{"date":82,"type":83},"2025-08-03","ACTUAL",{"date":85,"type":65},"2025-09-15",{"date":87,"type":65},"2026-02-28",{"name":5,"class":6}]